18 Feb
European Cancer Conference and American College of Gastroenterology: Melanoma
When early reports of increased mortality rates caused the premature discontinuation of the European Organisation for Research and Treatment of Cancer trial (EORTC 18961) of a post-surgical vaccine for patients with node-negative malignant melanoma, it cast a pall over the vaccine horizon, noted Dr. Eggermont. At a Pfizer-sponsored satellite symposium on cytotoxic T-lymphocyte antigen-4 (CTLA-4) [...]